CYTEK BIOSCIENCES, INC. (CTKB) Return on equity 2021–2025
CYTEK BIOSCIENCES, INC. (CTKB) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-19.5%FY2025 · since FY2021: 0.7% → -19.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -19.5% | -17.9 pp |
| FY2024 | -1.5% | +1.6 pp |
| FY2023 | -3.1% | -3.7 pp |
| FY2022 | 0.6% | -0.2 pp |
| FY2021 | 0.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice